Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
52 week low
|
Expensive Underperformer
425.9500
-16.00
(
-3.62
%)
NSE
Jan 16, 2026
15:31 PM
New 52W Low today
Volume:
534.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
29 Feb 2024
52 week low
425.95
-3.62%
SUVEN PHARMACEUTICALS LIMITED
Sell:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 571
Recommendation
Target
Geojit BNP Paribas
Cohance Lifesciences Ltd. is trading below all available SMAs
More from Cohance Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - January 16, 2026
The Baseline |
16 Jan 2026, 06:00PM
Market closes higher, buoyed by a rally in IT stocks
Trendlyne Marketwatch |
16 Jan 2026, 04:20PM
Nifty 50 outlook: Hopes rise for 2026 after a volatile year
The Baseline |
15 Jan 2026, 01:13PM